Literature DB >> 17653096

Molecular mimicry in inducing DNA damage between HIV-1 Vpr and the anticancer agent, cisplatin.

K Siddiqui1, L Del Valle, N Morellet, J Cui, M Ghafouri, R Mukerjee, K Urbanska, S Fan, C B Pattillo, S L Deshmane, M F Kiani, R Ansari, K Khalili, B P Roques, K Reiss, S Bouaziz, S Amini, A Srinivasan, B E Sawaya.   

Abstract

The human immunodeficiency virus type 1 (HIV-1) viral protein R (vpr) gene is an evolutionarily conserved gene among the primate lentiviruses. Several functions are attributed to Vpr including the ability to cause cell death, cell cycle arrest, apoptosis and DNA damage. The Vpr domain responsible for DNA damage as well as the mechanism(s) through which Vpr induces this damage is unknown. Using site-directed mutagenesis, we identified the helical domain II within Vpr (aa 37-50) as the region responsible for causing DNA damage. Interestingly, Vpr Delta(37-50) failed to cause cell cycle arrest or apoptosis, to induce Ku70 or Ku80 and to suppress tumor growth, but maintained its capability to activate the HIV-1 LTR, to localize to the nucleus and to promote nonhomologous end-joining. In addition, our cytogenetic data indicated that helical domain II induced chromosomal aberrations, which mimicked those induced by cisplatin, an anticancer agent. This novel molecular mimicry function of Vpr might lead to its potential therapeutic use as a tumor suppressor.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17653096     DOI: 10.1038/sj.onc.1210632

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  6 in total

1.  Inhibition of NF-κB activity by HIV-1 Vpr is dependent on Vpr binding protein.

Authors:  Michael Kogan; Satish Deshmane; Bassel E Sawaya; Edward J Gracely; Kamel Khalili; Jay Rappaport
Journal:  J Cell Physiol       Date:  2013-04       Impact factor: 6.384

2.  HIV-1 Vpr deregulates calcium secretion in neural cells.

Authors:  Inna Rom; Satish L Deshmane; Ruma Mukerjee; Kamel Khalili; Shohreh Amini; Bassel E Sawaya
Journal:  Brain Res       Date:  2009-03-25       Impact factor: 3.252

3.  HIV-1 Vpr triggers mitochondrial destruction by impairing Mfn2-mediated ER-mitochondria interaction.

Authors:  Chih-Yang Huang; Shu-Fen Chiang; Tze-Yi Lin; Shiow-Her Chiou; Kuan-Chih Chow
Journal:  PLoS One       Date:  2012-03-16       Impact factor: 3.240

4.  The HIV-derived protein Vpr52-96 has anti-glioma activity in vitro and in vivo.

Authors:  Jens Kübler; Stefanie Kirschner; Linda Hartmann; Grit Welzel; Maren Engelhardt; Carsten Herskind; Marlon R Veldwijk; Christian Schultz; Manuela Felix; Gerhard Glatting; Patrick Maier; Frederik Wenz; Marc A Brockmann; Frank A Giordano
Journal:  Oncotarget       Date:  2016-07-19

5.  The human immunodeficiency virus type 1 Vpr protein and its carboxy-terminally truncated form induce apoptosis in tumor cells.

Authors:  Mizuho Nonaka; Yoshie Hashimoto; Shin-Nosuke Takeshima; Yoko Aida
Journal:  Cancer Cell Int       Date:  2009-08-12       Impact factor: 5.722

6.  Structural alteration of DNA induced by viral protein R of HIV-1 triggers the DNA damage response.

Authors:  Kenta Iijima; Junya Kobayashi; Yukihito Ishizaka
Journal:  Retrovirology       Date:  2018-01-16       Impact factor: 4.602

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.